340B Drug Pricing Program
The AHA June 4 filed an amicus brief (/amicus-brief/2025-06-04-aha-files-brief-defending-tennessees-340b-contract-pharmacy-law) in the U.S. District Court for the Middle District of Tennessee in defense of the state鈥檚 340B contract pharmacy law prohibiting drug companies from鈥
AHA files brief defending Tennessee鈥檚 340B contract pharmacy law.
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B 鈥渞ebate models鈥 before they can be implemented, which the department has not yet done for any of the models pursued by the plaintiff drug companies.
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state鈥檚 340B contract pharmacy law prohibiting drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-鈥
The AHA May 9 urged the Department of Health and Human Services to deny drug companies鈥 requests to approve their unlawful 340B rebate models.
340B Advocacy Alliance Bulletin for May 14, 2025.
AHA, others files brief defending South Dakota's 340B contract pharmacy law.
AHA urges Secretary U.S. Department of Health and Human Services to reject the effort by several large drug companies to undermine the 340B Drug Pricing Program by imposing a 鈥渞ebate model,鈥
The AHA May 8 filed an amicus brief in the U.S. District Court for the District of Nebraska in defense of the state鈥檚 340B contract pharmacy law prohibiting drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house鈥
AHA, others file brief in defense of Nebraska鈥檚 340B contract pharmacy law.